Synergistic Minimally Invasive Surgery and Deferoxamine in ICH (NCT07162363)
Synergistic Intervention of Minimally Invasive Surgery and Deferoxamine in Intracerebral Hemorrhage (SMAD)
🩺 Plain-English Summary (8th-Grade Level)
This is a multicenter, randomized, open-label trial designed to evaluate the safety, feasibility, and efficacy of combining minimally invasive surgery (MIS) with intravenous deferoxamine (DFX) for the treatment of spontaneous intracerebral hemorrhage (ICH), compared to standard medical care. This trial represents the first investigation of a dual-modality approach in ICH, integrating mechanical clot evacuation with biochemical neuroprotection, with the goal of improving neurological outcomes.
Who can join: Review the eligibility criteria below.
Location: University of Illinois Hospital & Health Sciences System (UI Health) — Chicago, Illinois
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Illinois Hospital & Health Sciences System (UI Health) — Chicago, Illinois
📞 Contact the Study Coordinator
Phone: (312) 996-4842
Email: gatwal@uic.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Intracerebral Hemorrhage
- ROSE-Longitudinal Assessment With Neuroimaging — Chicago, Illinois
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Birmingham, Alabama
- Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke — New Haven, Connecticut
- Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH) — Birmingham, Alabama
- Auricular VNS Following Intracerebral Hemorrhage — St Louis, Missouri
Explore by condition: All Intracerebral Hemorrhage clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.